• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Shionogi-ViiV Healthcare LLC - Articles and news items

injectable-hiv

ViiV Healthcare to evaluate injectable HIV treatment

Industry news / 23 November 2016 / Niamh Louise Marriott, Digital Content Producer

The two studies, FLAIR and ATLAS, will examine the safety and efficacy of monthly dosing with the two-drug, injectable regimen in both treatment-naïve…

GlaxoSmithKline logo

Shionogi-ViiV Healthcare announces completion of initial clinical registration package for dolutegravir in HIV

Industry news, News / 4 October 2012 / GlaxoSmithKline

Dolutegravir is not yet approved as a treatment for HIV…

GlaxoSmithKline logo
GlaxoSmithKline logo

Shionogi-ViiV Healthcare announces initial data from pivotal phase III study of dolutegravir in HIV

Industry news, News / 2 April 2012 / GlaxoSmithKline

SPRING-2 study meets primary endpoint of non-inferiority of dolutegravir…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +